PULMOCIS

This brand name is authorized in Austria, Croatia, Estonia, France, Hong Kong SAR China, Ireland, Malta, UK.

Active ingredients

The drug PULMOCIS contains one active pharmaceutical ingredient (API):

1	Technetium ⁹⁹ᵐTc macrosalb UNII ZIF514RVZR - ALBUMIN HUMAN
	Technetium ⁹⁹ᵐTc macrosalb is for diagnostic use only. It is used for pulmonary perfusion scintigraphy and radionuclide venography. When administered in usual doses, technetium [99mTc] macrosalb injection shows no pharmacodynamic effects detectable clinically or/and analytically.
	Read more about Technetium ⁹⁹ᵐTc macrosalb

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PULMOCIS Kit for radiopharmaceutical preparation	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
V09EB01	Technetium (99mTc) macrosalb	V Various → V09 Diagnostic radiopharmaceuticals → V09E Respiratory system → V09EB Technetium (99mTc), particles for injection
Discover more medicines within V09EB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1385232
FR	Base de données publique des médicaments	67986283
GB	Medicines & Healthcare Products Regulatory Agency	395330
HK	Department of Health Drug Office	66231
HR	Agencija za lijekove i medicinske proizvode	HR-H-430112868
MT	Medicines Authority	MA826/00502